Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
matthew.brook@nds.ox.ac.uk

Research groups

TWO

Matthew Brook

Clinical Research Fellow (TWO Study)

Recent publications

It never rains but pours: disseminated nocardiosis in a renal transplant patient from Nigeria - a case report.

Whitehead T. et al, (2025), BMC Infect Dis, 26

Regulatory T cell therapy is associated with distinct immune regulatory lymphocytic infiltrates in kidney transplants.

McCallion O. et al, (2025), Med, 6

case of disseminated autochthonous Cladophialophora bantiana infection in a renal transplant recipient in the UK.

Mackrill SW. et al, (2025), Lancet Infect Dis, 25, e104 - e112

Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation.

Brook MO. et al, (2024), Transplantation, 108, 2278 - 2286

GMP Protocol for the Manufacture of Tregs for Clinical Application.

O'Neil A. et al, (2023), 2559, 205 - 227